Study of Infliximab Therapy for IVIG Treatment-resistant Kawasaki Disease.
Completed
- Conditions
- Kawasaki Disease
- Registration Number
- JPRN-jRCT1091220086
- Lead Sponsor
- Investigator-initiated Clinical Research (in-house)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patients against IVIG Treatment-resistant Kawasaki Disease (less than 37.5 degrees C within a 24-hour period)
Exclusion Criteria
Past History of Demyelinating Disease
Patients less than 6 months of taking BCG
Patients with lung thberculosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complication of Coronary Artery Aneurysm after Infliximab Injection
- Secondary Outcome Measures
Name Time Method Complication of Coronary Artery Aneurysm after Injection (up to One year after Injection) <br>Pyretolysis (within a 48-hour period after injection)<br>Adverse Event